Barclays
CAH icon

Barclays’s Cardinal Health CAH Stock Holding History

Barclays’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$210M Sell
993,914
-214,685
-18% -$46.2M 0.05% 288
2025
Q4 		$248M Sell
1,208,599
-375,615
-24% -$70.7M 0.06% 237
2025
Q3 		$249M Buy
1,584,214
+827,446
+109% +$128M 0.05% 250
2025
Q2 		$127M Buy
756,768
+43,765
+6% +$6.5M 0.03% 394
2025
Q1 		$98.2M Buy
713,003
+213,428
+43% +$27.2M 0.03% 426
2024
Q4 		$59.1M Sell
499,575
-207,829
-29% -$24.3M 0.02% 592
2024
Q3 		$78.2M Buy
707,404
+53,851
+8% +$5.63M 0.02% 516
2024
Q2 		$64.3M Sell
653,553
-7,264
-1% -$740K 0.02% 543
2024
Q1 		$73.9M Sell
660,817
-55,971
-8% -$6.04M 0.03% 466
2023
Q4 		$72.3M Buy
716,788
+150,455
+27% +$14.9M 0.03% 522
2023
Q3 		$49.2M Sell
566,333
-127,143
-18% -$11.5M 0.03% 495
2023
Q2 		$65.6M Buy
693,476
+74,832
+12% +$6.32M 0.04% 374
2023
Q1 		$46.7M Sell
618,644
-51,199
-8% -$3.86M 0.02% 490
2022
Q4 		$51.5M Buy
669,843
+82,937
+14% +$6.3M 0.02% 473
2022
Q3 		$39.1M Buy
586,906
+90,295
+18% +$5.72M 0.04% 385
2022
Q2 		$26M Sell
496,611
-104,590
-17% -$5.94M 0.02% 608
2022
Q1 		$34.1M Sell
601,201
-322,269
-35% -$17.3M 0.03% 526
2021
Q4 		$47.5M Buy
923,470
+295,321
+47% +$14.5M 0.02% 598
2021
Q3 		$31.1M Buy
628,149
+104,819
+20% +$5.69M 0.01% 706
2021
Q2 		$29.9M Buy
523,330
+62,947
+14% +$3.68M 0.01% 709
2021
Q1 		$28M Buy
460,383
+96,320
+26% +$5.32M 0.02% 668
2020
Q4 		$19.5M Buy
364,063
+97,018
+36% +$5.03M 0.01% 847
2020
Q3 		$12.5M Buy
267,045
+73,861
+38% +$3.79M 0.01% 935
2020
Q2 		$10.1M Sell
193,184
-59,209
-23% -$3.05M 0.01% 956
2020
Q1 		$12.1M Sell
252,393
-879,085
-78% -$45.6M 0.01% 888
2019
Q4 		$57.2M Buy
1,131,478
+494,750
+78% +$25.6M 0.03% 446
2019
Q3 		$30M Buy
636,728
+10,359
+2% +$473K 0.02% 673
2019
Q2 		$29.5M Buy
626,369
+126,167
+25% +$5.82M 0.02% 720
2019
Q1 		$24.1M Sell
500,202
-357,038
-42% -$17.9M 0.02% 744
2018
Q4 		$38.2M Sell
857,240
-693,855
-45% -$36.2M 0.03% 472
2018
Q3 		$83.8M Buy
1,551,095
+542,166
+54% +$27.7M 0.06% 255
2018
Q2 		$49.3M Sell
1,008,929
-97,758
-9% -$5.54M 0.04% 360
2018
Q1 		$69.4M Buy
1,106,687
+463,881
+72% +$31.8M 0.05% 313
2017
Q4 		$39.4M Sell
642,806
-142,414
-18% -$8.8M 0.03% 494
2017
Q3 		$52.5M Buy
785,220
+249,914
+47% +$17.7M 0.05% 279
2017
Q2 		$41.7M Buy
535,306
+239,301
+81% +$18.1M 0.04% 330
2017
Q1 		$24.1M Buy
296,005
+119,171
+67% +$9.38M 0.03% 488
2016
Q4 		$12.7M Buy
176,834
+78,674
+80% +$5.69M 0.01% 817
2016
Q3 		$7.63M Sell
98,160
-92,449
-49% -$7.47M 0.01% 1027
2016
Q2 		$14.9M Buy
190,609
+36,616
+24% +$2.92M 0.02% 645
2016
Q1 		$12.5M Sell
153,993
-3,730
-2% -$303K 0.02% 663
2015
Q4 		$14M Buy
157,723
+38,422
+32% +$3.26M 0.02% 726
2015
Q3 		$9.07M Sell
119,301
-146,176
-55% -$12.2M 0.01% 999
2015
Q2 		$22M Buy
265,477
+83,372
+46% +$7.36M 0.02% 605
2015
Q1 		$16.4M Sell
182,105
-76,521
-30% -$6.59M 0.02% 802
2014
Q4 		$20.7M Buy
258,626
+40,378
+19% +$3.19M 0.02% 742
2014
Q3 		$16.1M Buy
218,248
+14,135
+7% +$1.03M 0.02% 859
2014
Q2 		$13.9M Sell
204,113
-66,090
-24% -$4.5M 0.01% 934
2014
Q1 		$18.6M Sell
270,203
-92,161
-25% -$6.41M 0.02% 741
2013
Q4 		$23.9M Buy
362,364
+69,585
+24% +$4.25M 0.02% 667
2013
Q3 		$15.2M Buy
292,779
+22,959
+9% +$1.17M 0.02% 843
2013
Q2 		$12.7M Buy
+269,820
New +$12.3M 0.02% 901

Other funds holding CAH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Barclays's CAH Position: Q1 2026 in Review

Barclays reduced its Cardinal Health (CAH) stake by 18% in Q1 2026, selling an estimated $46.2M and leaving 993,914 shares worth $210M. The position accounts for 0.05% of the portfolio, ranked #288.

Barclays first reported a position in CAH in Q2 2013 and has held it in 52 quarters since. The position peaked at $249M in Q3 2025. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Barclays held 993,914 shares of Cardinal Health worth $210M as of Q1 2026.
  • Barclays sold 214,685 Cardinal Health shares in Q1 2026, an estimated $46.2M.
  • Cardinal Health made up 0.05% of Barclays's portfolio in Q1 2026, its #288 holding.
  • Barclays first reported a position in Cardinal Health in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Cardinal Health position peaked at $249M in Q3 2025.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.